Global Anthrax Vaccines Market Growth 2019-2024 | Analytical Research Cognizance
Published by ARCLI001
Report ID 250038
Published date Feb 11, 2019
Category Pharmaceuticals and Healthcare
Total Pages 176
Choose license type Buy Now
Request a Sample Enquiry Before Buying Check Discount

Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.

The classification of Anthrax Vaccines includes Live Vaccines and Cell free PA Vaccines, and the revenue proportion of Live Vaccines in 2016 is about 43%.

Anthrax Vaccines are widely used for human and animal. The most proportion of Anthrax Vaccines is used for animal, and the consumption proportion is about 95.1% in 2016.

South America region is the largest supplier of Anthrax Vaccines, with a production market share nearly 34.7% in 2016. Europe is the second largest supplier of Anthrax Vaccines, enjoying production market share nearly 17.6% in 2016.

South America is the largest sales place, with a sales market share nearly 39.3% in 2016. Following South America, Europe is the second largest sales place with the sales market share of 19.1%.

Along with the development of China 's Agricultural technology, there is a lot Chinese local manufacturer can produce Anthrax Vaccines, with the increasing demand, more and more manufactures will go into Anthrax Vaccines industry.
Market competition is intense. Emergent BioSolutions is the major manufacturer of Anthrax Vaccines used for human, Merial, Merck, Zoetis, Bayer Sanidad Animal,Colorado Serum, etc. are is the major manufacturer of Anthrax Vaccines used for animal, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

According to this study, over the next five years the Anthrax Vaccines market will register a 7.5% CAGR in terms of revenue, the global market size will reach US$ 720 million by 2024, from US$ 500 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anthrax Vaccines business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Anthrax Vaccines market by product type, application, key manufacturers and key regions and countries.

This study considers the Anthrax Vaccines value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Live Vaccines
Cell free PA Vaccines

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Human Use
Animal Use

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Emergent BioSolutions
Merial
Merck
Zoetis 
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Anthrax Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Anthrax Vaccines market by identifying its various subsegments.
Focuses on the key global Anthrax Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anthrax Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Anthrax Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Chapter One: Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

Chapter Two: Executive Summary
2.1 World Market Overview
2.1.1 Global Anthrax Vaccines Consumption 2014-2024
2.1.2 Anthrax Vaccines Consumption CAGR by Region
2.2 Anthrax Vaccines Segment by Type
2.2.1 Live Vaccines
2.2.2 Cell free PA Vaccines
2.3 Anthrax Vaccines Consumption by Type
2.3.1 Global Anthrax Vaccines Consumption Market Share by Type (2014-2019)
2.3.2 Global Anthrax Vaccines Revenue and Market Share by Type (2014-2019)
2.3.3 Global Anthrax Vaccines Sale Price by Type (2014-2019)
2.4 Anthrax Vaccines Segment by Application
2.4.1 Human Use
2.4.2 Animal Use
2.5 Anthrax Vaccines Consumption by Application
2.5.1 Global Anthrax Vaccines Consumption Market Share by Application (2014-2019)
2.5.2 Global Anthrax Vaccines Value and Market Share by Application (2014-2019)
2.5.3 Global Anthrax Vaccines Sale Price by Application (2014-2019)

Chapter Three: Global Anthrax Vaccines by Players
3.1 Global Anthrax Vaccines Sales Market Share by Players
3.1.1 Global Anthrax Vaccines Sales by Players (2017-2019)
3.1.2 Global Anthrax Vaccines Sales Market Share by Players (2017-2019)
3.2 Global Anthrax Vaccines Revenue Market Share by Players
3.2.1 Global Anthrax Vaccines Revenue by Players (2017-2019)
3.2.2 Global Anthrax Vaccines Revenue Market Share by Players (2017-2019)
3.3 Global Anthrax Vaccines Sale Price by Players
3.4 Global Anthrax Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Anthrax Vaccines Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Anthrax Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

Chapter Four: Anthrax Vaccines by Regions
4.1 Anthrax Vaccines by Regions
4.1.1 Global Anthrax Vaccines Consumption by Regions
4.1.2 Global Anthrax Vaccines Value by Regions
4.2 Americas Anthrax Vaccines Consumption Growth
4.3 APAC Anthrax Vaccines Consumption Growth
4.4 Europe Anthrax Vaccines Consumption Growth
4.5 Middle East & Africa Anthrax Vaccines Consumption Growth

Chapter Five: Americas
5.1 Americas Anthrax Vaccines Consumption by Countries
5.1.1 Americas Anthrax Vaccines Consumption by Countries (2014-2019)
5.1.2 Americas Anthrax Vaccines Value by Countries (2014-2019)
5.2 Americas Anthrax Vaccines Consumption by Type
5.3 Americas Anthrax Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

Chapter Six: APAC
6.1 APAC Anthrax Vaccines Consumption by Countries
6.1.1 APAC Anthrax Vaccines Consumption by Countries (2014-2019)
6.1.2 APAC Anthrax Vaccines Value by Countries (2014-2019)
6.2 APAC Anthrax Vaccines Consumption by Type
6.3 APAC Anthrax Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

Chapter Seven: Europe
7.1 Europe Anthrax Vaccines by Countries
7.1.1 Europe Anthrax Vaccines Consumption by Countries (2014-2019)
7.1.2 Europe Anthrax Vaccines Value by Countries (2014-2019)
7.2 Europe Anthrax Vaccines Consumption by Type
7.3 Europe Anthrax Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

Chapter Eight: Middle East & Africa
8.1 Middle East & Africa Anthrax Vaccines by Countries
8.1.1 Middle East & Africa Anthrax Vaccines Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Anthrax Vaccines Value by Countries (2014-2019)
8.2 Middle East & Africa Anthrax Vaccines Consumption by Type
8.3 Middle East & Africa Anthrax Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

Chapter Nine: Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

Chapter Ten: Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Anthrax Vaccines Distributors
10.3 Anthrax Vaccines Customer

Chapter Eleven: Global Anthrax Vaccines Market Forecast
11.1 Global Anthrax Vaccines Consumption Forecast (2019-2024)
11.2 Global Anthrax Vaccines Forecast by Regions
11.2.1 Global Anthrax Vaccines Forecast by Regions (2019-2024)
11.2.2 Global Anthrax Vaccines Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Anthrax Vaccines Forecast by Type
11.8 Global Anthrax Vaccines Forecast by Application

Chapter Twelve: Key Players Analysis
12.1 Emergent BioSolutions
12.1.1 Company Details
12.1.2 Anthrax Vaccines Product Offered
12.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Emergent BioSolutions News
12.2 Merial
12.2.1 Company Details
12.2.2 Anthrax Vaccines Product Offered
12.2.3 Merial Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Merial News
12.3 Merck
12.3.1 Company Details
12.3.2 Anthrax Vaccines Product Offered
12.3.3 Merck Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Merck News
12.4 Zoetis 
12.4.1 Company Details
12.4.2 Anthrax Vaccines Product Offered
12.4.3 Zoetis  Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Zoetis  News
12.5 Bayer Sanidad Animal
12.5.1 Company Details
12.5.2 Anthrax Vaccines Product Offered
12.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Bayer Sanidad Animal News
12.6 Colorado Serum
12.6.1 Company Details
12.6.2 Anthrax Vaccines Product Offered
12.6.3 Colorado Serum Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Colorado Serum News
12.7 PharmAthene
12.7.1 Company Details
12.7.2 Anthrax Vaccines Product Offered
12.7.3 PharmAthene Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 PharmAthene News
12.8 Tiankang
12.8.1 Company Details
12.8.2 Anthrax Vaccines Product Offered
12.8.3 Tiankang Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Tiankang News
12.9 Biogénesis-Bago
12.9.1 Company Details
12.9.2 Anthrax Vaccines Product Offered
12.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Biogénesis-Bago News
12.10 CAVAC
12.10.1 Company Details
12.10.2 Anthrax Vaccines Product Offered
12.10.3 CAVAC Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 CAVAC News
12.11 Rosenbusch
12.12 Agrovet
12.13 Vecol
12.14 CVCRI
12.15 IVPM
12.16 Prondil
12.17 CDV
12.18 Indian Immunologicals
12.19 Botswana Vaccine Institute
12.20 Ceva Santé Animale
12.21 Intervac
12.22 JOVAC

Chapter Thirteen: Research Findings and Conclusion

List of Tables and Figures
Figure Picture of Anthrax Vaccines
Table Product Specifications of Anthrax Vaccines
Figure Anthrax Vaccines Report Years Considered
Figure Market Research Methodology
Figure Global Anthrax Vaccines Consumption Growth Rate 2014-2024 (M Doses)
Figure Global Anthrax Vaccines Value Growth Rate 2014-2024 ($ Millions)
Table Anthrax Vaccines Consumption CAGR by Region 2014-2024 ($ Millions)
Figure Product Picture of Live Vaccines
Table Major Players of Live Vaccines
Figure Product Picture of Cell free PA Vaccines
Table Major Players of Cell free PA Vaccines
Table Global Consumption Sales by Type (2014-2019)
Table Global Anthrax Vaccines Consumption Market Share by Type (2014-2019)
Figure Global Anthrax Vaccines Consumption Market Share by Type (2014-2019)
Table Global Anthrax Vaccines Revenue by Type (2014-2019) ($ million)
Table Global Anthrax Vaccines Value Market Share by Type (2014-2019) ($ Millions)
Figure Global Anthrax Vaccines Value Market Share by Type (2014-2019)
Table Global Anthrax Vaccines Sale Price by Type (2014-2019)
Figure Anthrax Vaccines Consumed in Human Use
Figure Global Anthrax Vaccines Market: Human Use (2014-2019) (M Doses)
Figure Global Anthrax Vaccines Market: Human Use (2014-2019) ($ Millions)
Figure Global Human Use YoY Growth ($ Millions)
Figure Anthrax Vaccines Consumed in Animal Use
Figure Global Anthrax Vaccines Market: Animal Use (2014-2019) (M Doses)
Figure Global Anthrax Vaccines Market: Animal Use (2014-2019) ($ Millions)
Figure Global Animal Use YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2014-2019)
Table Global Anthrax Vaccines Consumption Market Share by Application (2014-2019)
Figure Global Anthrax Vaccines Consumption Market Share by Application (2014-2019)
Table Global Anthrax Vaccines Value by Application (2014-2019)
Table Global Anthrax Vaccines Value Market Share by Application (2014-2019)
Figure Global Anthrax Vaccines Value Market Share by Application (2014-2019)
Table Global Anthrax Vaccines Sale Price by Application (2014-2019)
Table Global Anthrax Vaccines Sales by Players (2017-2019) (M Doses)
Table Global Anthrax Vaccines Sales Market Share by Players (2017-2019)
Figure Global Anthrax Vaccines Sales Market Share by Players in 2017
Figure Global Anthrax Vaccines Sales Market Share by Players in 2018
Table Global Anthrax Vaccines Revenue by Players (2017-2019) ($ Millions)
Table Global Anthrax Vaccines Revenue Market Share by Players (2017-2019)
Figure Global Anthrax Vaccines Revenue Market Share by Players in 2017
Figure Global Anthrax Vaccines Revenue Market Share by Players in 2018
Table Global Anthrax Vaccines Sale Price by Players (2017-2019)
Figure Global Anthrax Vaccines Sale Price by Players in 2018
Table Global Anthrax Vaccines Manufacturing Base Distribution and Sales Area by Players
Table Players Anthrax Vaccines Products Offered
Table Anthrax Vaccines Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table Global Anthrax Vaccines Consumption by Regions 2014-2019 (M Doses)
Table Global Anthrax Vaccines Consumption Market Share by Regions 2014-2019
Figure Global Anthrax Vaccines Consumption Market Share by Regions 2014-2019
Table Global Anthrax Vaccines Value by Regions 2014-2019 ($ Millions)
Table Global Anthrax Vaccines Value Market Share by Regions 2014-2019
Figure Global Anthrax Vaccines Value Market Share by Regions 2014-2019
Figure Americas Anthrax Vaccines Consumption 2014-2019 (M Doses)
Figure Americas Anthrax Vaccines Value 2014-2019 ($ Millions)
Figure APAC Anthrax Vaccines Consumption 2014-2019 (M Doses)
Figure APAC Anthrax Vaccines Value 2014-2019 ($ Millions)
Figure Europe Anthrax Vaccines Consumption 2014-2019 (M Doses)
Figure Europe Anthrax Vaccines Value 2014-2019 ($ Millions)
Figure Middle East & Africa Anthrax Vaccines Consumption 2014-2019 (M Doses)
Figure Middle East & Africa Anthrax Vaccines Value 2014-2019 ($ Millions)
Table Americas Anthrax Vaccines Consumption by Countries (2014-2019) (M Doses)
Table Americas Anthrax Vaccines Consumption Market Share by Countries (2014-2019)
Figure Americas Anthrax Vaccines Consumption Market Share by Countries in 2018
Table Americas Anthrax Vaccines Value by Countries (2014-2019) ($ Millions)
Table Americas Anthrax Vaccines Value Market Share by Countries (2014-2019)
Figure Americas Anthrax Vaccines Value Market Share by Countries in 2018
Table Americas Anthrax Vaccines Consumption by Type (2014-2019) (M Doses)
Table Americas Anthrax Vaccines Consumption Market Share by Type (2014-2019)
Figure Americas Anthrax Vaccines Consumption Market Share by Type in 2018
Table Americas Anthrax Vaccines Consumption by Application (2014-2019) (M Doses)
Table Americas Anthrax Vaccines Consumption Market Share by Application (2014-2019)
Figure Americas Anthrax Vaccines Consumption Market Share by Application in 2018
Figure United States Anthrax Vaccines Consumption Growth 2014-2019 (M Doses)
Figure United States Anthrax Vaccines Value Growth 2014-2019 ($ Millions)
Figure Canada Anthrax Vaccines Consumption Growth 2014-2019 (M Doses)
Figure Canada Anthrax Vaccines Value Growth 2014-2019 ($ Millions)
Figure Mexico Anthrax Vaccines Consumption Growth 2014-2019 (M Doses)
Figure Mexico Anthrax Vaccines Value Growth 2014-2019 ($ Millions)
Table APAC Anthrax Vaccines Consumption by Countries (2014-2019) (M Doses)
Table APAC Anthrax Vaccines Consumption Market Share by Countries (2014-2019)
Figure APAC Anthrax Vaccines Consumption Market Share by Countries in 2018
Table APAC Anthrax Vaccines Value by Countries (2014-2019) ($ Millions)
Table APAC Anthrax Vaccines Value Market Share by Countries (2014-2019)
Figure APAC Anthrax Vaccines Value Market Share by Countries in 2018
Table APAC Anthrax Vaccines Consumption by Type (2014-2019) (M Doses)
Table APAC Anthrax Vaccines Consumption Market Share by Type (2014-2019)
Figure APAC Anthrax Vaccines Consumption Market Share by Type in 2018
Table APAC Anthrax Vaccines Consumption by Application (2014-2019) (M Doses)
Table APAC Anthrax Vaccines Consumption Market Share by Application (2014-2019)
Figure APAC Anthrax Vaccines Consumption Market Share by Application in 2018
Figure China Anthrax Vaccines Consumption Growth 2014-2019 (M Doses)
Figure China Anthrax Vaccines Value Growth 2014-2019 ($ Millions)
Figure Japan Anthrax Vaccines Consumption Growth 2014-2019 (M Doses)
Figure Japan Anthrax Vaccines Value Growth 2014-2019 ($ Millions)
Figure Korea Anthrax Vaccines Consumption Growth 2014-2019 (M Doses)
Figure Korea Anthrax Vaccines Value Growth 2014-2019 ($ Millions)
Figure Southeast Asia Anthrax Vaccines Consumption Growth 2014-2019 (M Doses)
Figure Southeast Asia Anthrax Vaccines Value Growth 2014-2019 ($ Millions)
Figure India Anthrax Vaccines Consumption Growth 2014-2019 (M Doses)
Figure India Anthrax Vaccines Value Growth 2014-2019 ($ Millions)
Figure Australia Anthrax Vaccines Consumption Growth 2014-2019 (M Doses)
Figure Australia Anthrax Vaccines Value Growth 2014-2019 ($ Millions)
Table Europe Anthrax Vaccines Consumption by Countries (2014-2019) (M Doses)
Table Europe Anthrax Vaccines Consumption Market Share by Countries (2014-2019)
Figure Europe Anthrax Vaccines Consumption Market Share by Countries in 2018
Table Europe Anthrax Vaccines Value by Countries (2014-2019) ($ Millions)
Table Europe Anthrax Vaccines Value Market Share by Countries (2014-2019)
Figure Europe Anthrax Vaccines Value Market Share by Countries in 2018
Table Europe Anthrax Vaccines Consumption by Type (2014-2019) (M Doses)
Table Europe Anthrax Vaccines Consumption Market Share by Type (2014-2019)
Figure Europe Anthrax Vaccines Consumption Market Share by Type in 2018
Table Europe Anthrax Vaccines Consumption by Application (2014-2019) (M Doses)
Table Europe Anthrax Vaccines Consumption Market Share by Application (2014-2019)
Figure Europe Anthrax Vaccines Consumption Market Share by Application in 2018
Figure Germany Anthrax Vaccines Consumption Growth 2014-2019 (M Doses)
Figure Germany Anthrax Vaccines Value Growth 2014-2019 ($ Millions)
Figure France Anthrax Vaccines Consumption Growth 2014-2019 (M Doses)
Figure France Anthrax Vaccines Value Growth 2014-2019 ($ Millions)
Figure UK Anthrax Vaccines Consumption Growth 2014-2019 (M Doses)
Figure UK Anthrax Vaccines Value Growth 2014-2019 ($ Millions)
Figure Italy Anthrax Vaccines Consumption Growth 2014-2019 (M Doses)
Figure Italy Anthrax Vaccines Value Growth 2014-2019 ($ Millions)
Figure Russia Anthrax Vaccines Consumption Growth 2014-2019 (M Doses)
Figure Russia Anthrax Vaccines Value Growth 2014-2019 ($ Millions)
Figure Spain Anthrax Vaccines Consumption Growth 2014-2019 (M Doses)
Figure Spain Anthrax Vaccines Value Growth 2014-2019 ($ Millions)
Table Middle East & Africa Anthrax Vaccines Consumption by Countries (2014-2019) (M Doses)
Table Middle East & Africa Anthrax Vaccines Consumption Market Share by Countries (2014-2019)
Figure Middle East & Africa Anthrax Vaccines Consumption Market Share by Countries in 2018
Table Middle East & Africa Anthrax Vaccines Value by Countries (2014-2019) ($ Millions)
Table Middle East & Africa Anthrax Vaccines Value Market Share by Countries (2014-2019)
Figure Middle East & Africa Anthrax Vaccines Value Market Share by Countries in 2018
Table Middle East & Africa Anthrax Vaccines Consumption by Type (2014-2019) (M Doses)
Table Middle East & Africa Anthrax Vaccines Consumption Market Share by Type (2014-2019)
Figure Middle East & Africa Anthrax Vaccines Consumption Market Share by Type in 2018
Table Middle East & Africa Anthrax Vaccines Consumption by Application (2014-2019) (M Doses)
Table Middle East & Africa Anthrax Vaccines Consumption Market Share by Application (2014-2019)
Figure Middle East & Africa Anthrax Vaccines Consumption Market Share by Application in 2018
Figure Egypt Anthrax Vaccines Consumption Growth 2014-2019 (M Doses)
Figure Egypt Anthrax Vaccines Value Growth 2014-2019 ($ Millions)
Figure South Africa Anthrax Vaccines Consumption Growth 2014-2019 (M Doses)
Figure South Africa Anthrax Vaccines Value Growth 2014-2019 ($ Millions)
Figure Israel Anthrax Vaccines Consumption Growth 2014-2019 (M Doses)
Figure Israel Anthrax Vaccines Value Growth 2014-2019 ($ Millions)
Figure Turkey Anthrax Vaccines Consumption Growth 2014-2019 (M Doses)
Figure Turkey Anthrax Vaccines Value Growth 2014-2019 ($ Millions)
Figure GCC Countries Anthrax Vaccines Consumption Growth 2014-2019 (M Doses)
Figure GCC Countries Anthrax Vaccines Value Growth 2014-2019 ($ Millions)
Table Anthrax Vaccines Distributors List
Table Anthrax Vaccines Customer List
Figure Global Anthrax Vaccines Consumption Growth Rate Forecast (2019-2024) (M Doses)
Figure Global Anthrax Vaccines Value Growth Rate Forecast (2019-2024) ($ Millions)
Table Global Anthrax Vaccines Consumption Forecast by Countries (2019-2024) (M Doses)
Table Global Anthrax Vaccines Consumption Market Forecast by Regions
Table Global Anthrax Vaccines Value Forecast by Countries (2019-2024) ($ Millions)
Table Global Anthrax Vaccines Value Market Share Forecast by Regions
Figure Americas Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure Americas Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure APAC Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure APAC Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure Europe Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure Europe Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure Middle East & Africa Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure Middle East & Africa Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure United States Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure United States Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure Canada Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure Canada Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure Mexico Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure Mexico Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure Brazil Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure Brazil Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure China Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure China Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure Japan Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure Japan Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure Korea Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure Korea Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure Southeast Asia Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure Southeast Asia Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure India Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure India Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure Australia Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure Australia Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure Germany Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure Germany Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure France Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure France Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure UK Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure UK Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure Italy Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure Italy Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure Russia Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure Russia Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure Spain Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure Spain Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure Egypt Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure Egypt Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure South Africa Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure South Africa Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure Israel Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure Israel Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure Turkey Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure Turkey Anthrax Vaccines Value 2019-2024 ($ Millions)
Figure GCC Countries Anthrax Vaccines Consumption 2019-2024 (M Doses)
Figure GCC Countries Anthrax Vaccines Value 2019-2024 ($ Millions)
Table Global Anthrax Vaccines Consumption Forecast by Type (2019-2024) (M Doses)
Table Global Anthrax Vaccines Consumption Market Share Forecast by Type (2019-2024)
Table Global Anthrax Vaccines Value Forecast by Type (2019-2024) ($ Millions)
Table Global Anthrax Vaccines Value Market Share Forecast by Type (2019-2024)
Table Global Anthrax Vaccines Consumption Forecast by Application (2019-2024) (M Doses)
Table Global Anthrax Vaccines Consumption Market Share Forecast by Application (2019-2024)
Table Global Anthrax Vaccines Value Forecast by Application (2019-2024) ($ Millions)
Table Global Anthrax Vaccines Value Market Share Forecast by Application (2019-2024)
Table Emergent BioSolutions Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Emergent BioSolutions Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Emergent BioSolutions Anthrax Vaccines Market Share (2017-2019)
Table Merial Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merial Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Merial Anthrax Vaccines Market Share (2017-2019)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Merck Anthrax Vaccines Market Share (2017-2019)
Table Zoetis  Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Zoetis  Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Zoetis  Anthrax Vaccines Market Share (2017-2019)
Table Bayer Sanidad Animal Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Bayer Sanidad Animal Anthrax Vaccines Market Share (2017-2019)
Table Colorado Serum Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Colorado Serum Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Colorado Serum Anthrax Vaccines Market Share (2017-2019)
Table PharmAthene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table PharmAthene Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure PharmAthene Anthrax Vaccines Market Share (2017-2019)
Table Tiankang Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Tiankang Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Tiankang Anthrax Vaccines Market Share (2017-2019)
Table Biogénesis-Bago Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogénesis-Bago Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Biogénesis-Bago Anthrax Vaccines Market Share (2017-2019)
Table CAVAC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CAVAC Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure CAVAC Anthrax Vaccines Market Share (2017-2019)
Table Rosenbusch Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Agrovet Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Vecol Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CVCRI Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table IVPM Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Prondil Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CDV Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Indian Immunologicals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Botswana Vaccine Institute Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ceva Santé Animale Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Intervac Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table JOVAC Basic Information, Manufacturing Base, Sales Area and Its Competitors